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Shiga toxin-producing Escherichia coli (STEC) comprises a broad group of bacteria, some of which cause
attaching and effacing (AE) lesions and enteritis in animals and humans. Non-O157 STEC serotypes contain
a gene (efa1) that mediates attachment to cultured epithelial cells. An almost-identical gene in enteropatho-
genic E. coli (lifA) encodes lymphostatin, which inhibits the proliferation of mitogen-activated lymphocytes and
the synthesis of proinflammatory cytokines. We have investigated the role of the efa1 gene in colonization of 4-
and 11-day-old conventional calves by STEC serotypes O5 and O111. Our findings show that Efa1 is required
for efficient colonization of the bovine intestinal tract by STEC, since efa1 deletion and insertion mutants were
shed in the feces in significantly lower numbers. In addition, efa1 mutations dramatically reduced the number
of bacteria associated with the intestinal epithelium. Expression and secretion of locus for enterocyte efface-
ment-encoded type III secreted proteins that are required for adhesion and AE-lesion formation were impaired
by mutation of efa1 in STEC but not by mutation of lifA in enteropathogenic E. coli. However, STEC efa1
mutants retain the ability to nucleate filamentous actin under sites of bacterial attachment to cultured
eukaryotic cells. Efa1 is only the second STEC factor shown to influence carriage of the bacteria in the bovine
intestine. Our data may have implications for strategies to reduce the prevalence of STEC in cattle.
Shiga toxin-producing Escherichia coli (STEC) comprises a
group of zoonotic enteric pathogens (43). In humans, infec-
tions with some STEC serotypes result in bloody or nonbloody
diarrhea, which may be complicated by hemorrhagic colitis and
severe renal and neurological sequelae, including hemolytic-
uremic syndrome (45). STEC is closely related to enteropatho-
genic E. coli (EPEC), which is a leading cause of infantile
diarrhea in developing countries, and share many of the EPEC
genes implicated in virulence (15, 49).
Cattle are an important reservoir of STEC (17), and human
infections frequently result from direct or indirect contact with
ruminant feces (19, 53). Strategies to lower the prevalence of
STEC in cattle therefore offer the possibility of reducing the
incidence of human infections. Natural and experimental in-
fection of calves with STEC results in efficient colonization of
the intestinal tract with large numbers of bacteria being shed in
the feces for several weeks (3, 6, 7, 8, 9, 10, 21, 46). Clinical
signs of STEC infection in calves may vary from subclinical to
dysentery depending on the serotype (35). The molecular basis
of intestinal colonization and STEC serotype host specificity is
poorly understood.
The bacterial outer membrane protein intimin is required
for intestinal colonization in colostrum-deprived neonatal
calves by E. coli O157:H7 and the induction of colonic edema
and diarrhea (9). Intimin is required for the formation of
intestinal attaching and effacing (AE) lesions, which are char-
acterized by intimate bacterial attachment to the apical surface
of enterocytes and the localized destruction of microvilli (15).
This histopathology is determined by the chromosomal locus
for enterocyte effacement (LEE), and also requires the LEE-
encoded Tir protein which is translocated into host cells via a
type III protein secretion system, where it acts as a receptor for
intimin (11). Intimin can also bind to 1-integrins (16) and
cell-surface localized nucleolin (52), though the consequence
of this is unknown. Intimin-null mutants still colonize some
compartments of the bovine intestinal tract (9), indicating that
other colonization factors and/or survival of the bacteria in the
intestinal lumen may be required.
Recently, Nicholls et al. identified a gene (efa1 [for E. coli
factor for adherence]) that mediates attachment of a clinical
O111:H STEC strain to cultured Chinese hamster ovary cells
(44). A TnphoA insertion in the STEC O111:H efa1 gene
gave rise to an enzymatically active alkaline phosphatase-Efa1
fusion protein, indicating that the gene is functionally ex-
pressed and has an extracytoplasmic domain (44). The efa1
gene is identical in size and 99.9% identical in nucleotide
sequence to the lifA gene in enteropathogenic E. coli (Table 1).
The lifA gene confers upon EPEC the ability to inhibit the
proliferation of human peripheral blood lymphocytes and the
mitogen-stimulated synthesis of interleukin-2 (IL-2), IL-4,
IL-5, and gamma interferon (30). The predicted product of lifA
(lymphostatin) also inhibits the proliferation of human and
murine gastrointestinal lymphocytes, indicating that it may
modulate mucosal immunity in the gut (28, 31, 37). Lympho-
statin specifically targets lymphoid cells and does not affect the
proliferation of epithelial cells, exert direct cytotoxic effects or
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increase apoptosis (30). The EPEC lifA and STEC efa1 genes
encode predicted proteins of 366 kDa that are 97.4% identical
at the amino acid level.
The efa1/lifA gene is present not only in STEC O111 and
EPEC but also in all non-O157 STEC serotypes tested and
related enteropathogens such as Citrobacter rodentium, Hafnia
alvei, and rabbit EPEC (30, 44). While E. coli O157:H7 lacks
the full-length efa1 gene a truncated version of efa1 exists in
the chromosome (Table 1) (24, 47). Screening of a bank of E.
coli O157:H7 mini-Tn5Km2 mutants has recently shown that a
transposon insertion upstream of the truncated efa1 gene re-
duces bacterial adherence to human colon carcinoma cells
(57), indicating that the truncated version of the gene may also
influence bacterial adhesion and intestinal colonization.
A large gene (toxB/l7095) with significant homology to efa1
also exists on the E. coli O157:H7 pO157 virulence plasmid (Ta-
ble 1) (4, 30, 36, 44). E. coli O157:H7 strains containing deriv-
atives of pO157 that lack toxB exhibit reduced adherence to
cultured epithelial cells (58). The authors reported that toxB in-
directly influences adherence by modulating the production and
secretion of LEE-encoded type III secreted proteins that are
required for the formation of AE lesions (58). The toxB gene has
also been suggested to be a functional homologue of lymphos-
tatin, since an E. coli O157:H7 strain cured of pO157 lacked
the ability to inhibit IL-2 and IL-4 synthesis in mitogen-activat-
ed human peripheral blood mononuclear cells (PBMCs) (30).
STEC O111 Efa1, EPEC LifA, and the E. coli O157:H7
ToxB predicted protein share 40% amino acid homology over
the N-terminal 470 amino acids (aa) with the N-terminal do-
mains of Clostridium difficile toxins A and B (Table 1) (4, 30,
36, 44). Large clostridial toxins (LCTs) act by glucosylating
small GTPases that regulate the actin cytoskeleton (29). This
activity is determined by the N-terminal 546 aa of toxin B and
is dependent on a DXD motif that is shared by eukaryotic
glycosyltransferases (5, 26). Efa1, LifA, and ToxB share ho-
mology with LCTs and eukaryotic glycosyltransferases in this
region and all three proteins contain the conserved DXD mo-
tif. Several open reading frames with homology to LCTs have
also been identified in the genome of Chlamydia trachomatis
(54) and were recently shown to be required for cytotoxicity
(2), indicating that LCT-homologues may influence pathogen-
esis in diverse pathogens.
Since Efa1 influences adhesion of STEC to eukaryotic cells
in vitro and may act as an inhibitor of lymphocyte proliferation,
we proposed that Efa1 may influence colonization of the bo-
vine intestine by non-O157 STEC. We have inoculated 4- and
11-day-old conventional calves orally with STEC O5 and O111
strains containing efa1 with deletion or insertion mutations,
respectively. Our results suggest a pivotal role for Efa1 in
intestinal colonization and enteropathogenesis in calves.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. STEC strain S102-9 (O5:H) was
isolated from an outbreak of calf dysentery in the United Kingdom (7). S102-9
Nalr is a spontaneous nalidixic acid-resistant derivative of S102-9 and exhibits
normal growth and adhesion characteristics in vitro. E. coli E45035N is a nalidixic
acid-resistant derivative of STEC O111:H isolated from the feces of a patient
with hemolytic-uremic syndrome (44). EBK4 is derived from E45035N and
contains an insertion of a kanamycin resistance cassette in efa1 (44). Both
E45035N and EBK4 were kindly supplied by E. Hartland, Monash University,
Melbourne, Australia. The prototypic EPEC strain E2348/69 (O127:H6) was
isolated by Levine et al. (34). E. coli K-12 strain HB101 [F (gpt-proA)62 leuB6
supE44 ara-14 galK2 lacY1 (mcrC-mrr) rpsL20 xyl-5 mtl-1 recA13] was used as a
control in some assays. Plasmid pCVD442 is a positive-selection suicide vector
containing blaM, the Bacillus subtilis sacBR genes, the mob region from plasmid
RP4 and a pir-dependent R6K origin of replication (13). pCVD442 and deriva-
tives were maintained in E. coli DH5 pir (48) and in E. coli S17-1pir for
conjugation (51). A cosmid containing lifA (pIV-8-A) (32) was kindly supplied by
M. Donnenberg, University of Maryland. Bacteria were isolated on Luria-Ber-
tani (LB) agar and cultivated in LB broth with the following antibiotics at the
indicated concentrations: ampicillin, 100 g/ml; kanamycin, 25 g/ml; nalidixic
acid, 25 g/ml. For oral inoculation studies bacteria were amplified in brain heart
infusion broth for 18 h at 37°C, and the absorbance at 600 nm was adjusted to
within 0.1 optical density units.
Cell lines. HeLa cells (ATCC CCL2) were cultivated in RPMI 1640 buffered
with sodium bicarbonate (2 g/liter) and supplemented with 10% (vol/vol) fetal
calf serum (PAA Laboratories GmbH, Linz, Austria) and L-glutamine (0.3 g/li-
ter). For adhesion assays, cells were seeded at 2  105 cells/35-mm-diameter dish
TABLE 1. LCT homologues in EPEC nd STECa
ORF Organism(s)(references) Amino acid homology Activity(ies) (reference[s])
9,669-bp chromosomal
ORFc
EPEC (lifA)  non-O157
STEC (efa1) REPECb
C. rodentium (30, 44)
40% homology over N-terminal 470
aa to C. difficile toxins A and B
EPEC LifA inhibits proliferation of human
PBMCs and intestinal-mononuclear cells
and the synthesis of IL-2, -4, and -5 and
IFN-	d (30); Efa1 influences adhesion of
O111:H STEC to CHO cells (44)
9,507-bp pO157-encoded
ORF
E. coli O157:H7 (4, 36) 40% homology over N-terminal 470
aa to C. difficile toxins A and B;
28% overall amino acid identity
(47% homology) to LifA
Influences adhesion of E. coli O157:H7 to
Caco-2 cells (58); mutation of toxB re-
duces expression and secretion of LEE-
encoded effectors (58)
1,299-bp chromosomal ORF
(frameshift results in con-
tiguous 825-bp ORF)
E. coli O157:H7 (24, 47) 40% over N-terminal 470 aa to
C. difficile toxins A and B
mini-Tn5Km insertion upstream of efa1

reduces adherence to Caco-2 cells (57)
a Nucleotide sequence accession numbers for the following are given parenthetically: EPEC O127:H6 lifA (AJ133705), STEC O111:H efa1 (AF159462), STEC
O157:H7 17095 (toxB) (AF074613), STEC O157:H7 efa1
 (AE005174).
b REPEC, rabbit enteropathogenic E. coli.
c ORF, open reading frame.
d IFN-	, gamma interferon.
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on glass coverslips and grown for 18 h at 37°C in a humidified 5% CO2 atmo-
sphere.
Routine DNA manipulation. Standard procedures were used for DNA extrac-
tion, cloning, PCR, and the verification of mutants by Southern hybridization
(50).
Construction of STEC O5:H efa1 and EPEC O127:H6 lifA mutants. The
STEC efa1 and EPEC lifA mutants contain deletions of the entire gene and
were constructed as follows. Sequences flanking the S102-9 efa1 gene were
separately amplified by PCR with Vent proofreading DNA polymerase (New
England Biolabs, Beverly, Mass.) using the primer pairs efa3 (5
 ATATATGA
GCTCGTGTAGCGGTATTCGGC 3
) plus efa7 (5
 CCCGTTGCTGCAATTA
ATTACATTTCCGCTTAA 3
) and efa8 (5
 CGGAAATGTAATTAATTGCA
GCAACGGGTA 3
) plus efa9 (5
 ATATATGAGCTCTTAGTTAAAAAGGT
TGTC 3
) (based on the sequence of STEC O111 efa1). The primary PCR
products were gel purified and combined in an overlapping PCR (27) using the
flanking primers efa3 and efa9. The secondary PCR product was then cloned into
pCVD442 via SacI sites incorporated into the primers. The resulting plasmid,
pCVDefa1 was introduced into S102-9 Nalr and E2348/69 by conjugation from
E. coli S17-1pir and merodiploids isolated on LB agar containing ampicillin and
nalidixic acid. Double recombinants were selected by growing merodiploids to
late-logarithmic phase in LB broth lacking ampicillin and plating onto LB agar
(minus NaCl) containing 5% (wt/vol) sucrose at 30°C. Sucrose-resistant colonies
were screened for deletions by colony PCR and recombinants verified by South-
ern hybridization. The deletions result in juxtaposition of the predicted start and
stop codons.
Adhesion assay. Adhesion of STEC strains to HeLa cells was quantified
essentially as described previously (39). Cells were stained with Hemacolor rapid
staining solutions (Merck, Darmstadt, Germany) and multiple images captured
at a magnification of 400 using a Leica DMLS microscope with a Polaroid
digital microscope camera. Fluorescent actin staining for the detection of F-actin
under sites of bacteria adhesion to HeLa cells was performed as described
previously (33), except that bacteria were incubated on the cells for a total of 8 h.
Lymphocyte proliferation assay. Bacterial lysates were prepared from 50-ml
overnight LB cultures. Cells were collected by centrifugation, washed, and re-
suspended in 5 ml of phosphate-buffered saline (PBS) and then disrupted by
sonication for 2 min total at 2-s intervals on ice. The lysate was centrifuged (1,000
 g for 10 min at 4°C) to remove cell debris, and the protein concentration was
determined by a colorimetric assay (Bio-Rad Laboratories, Hercules, Calif.).
Bovine PBMCs were isolated from fresh venous blood of ca. 6 month old healthy
calves by centrifugation at 2000  g on Histopaque 1083 gradients (Sigma
Chemical Company, St Louis, Mo.) for 40 min at room temperature. PBMCs
were aspirated, washed in PBS and collected by centrifugation at 2,000  g. The
cells were resuspended in RPMI 1640 buffered with sodium bicarbonate (2
g/liter) and supplemented with 10% (vol/vol) fetal calf serum, L-glutamine (0.3
g/liter), penicillin (100 U/ml), and streptomycin (100 g/ml). Cells were counted
on a hemocytometer and dispensed into 96-well microtiter plates. Cells (5  105)
were stimulated with concanavalin A (5 g/ml) in the presence of 50 g of
bacterial protein. Cultures, set up in quadruplicate, were incubated for 3 days at
37°C in 5% CO2 in a humidified atmosphere. Sixteen hours before harvest, cells
were pulsed with 1 C of [3H]thymidine (Amersham Pharmacia Biotech, Little
Chalfont, Buckinghamshire, United Kingdom) per well. Radioactivity incorpo-
rated into DNA was measured using a Beckman -scintillation counter and is
expressed as counts per minute.
Oral inoculation of calves and quantification of shedding. All animal exper-
iments were performed in accordance with the Animals (Scientific Procedures)
Act 1986 and were approved by the local Ethical Review Committee. Conven-
tional Friesian bull calves were fed on milk replacer twice daily with free access
to water. In the week prior to infection calves were screened for the absence of
STEC and Salmonella enterica by enrichment culture of rectal swabs on Sorbitol
MacConkey agar containing tellurite, or on brilliant green agar (Oxoid, Basing-
stoke, United Kingdom), respectively. Calves with diarrhea or excreting STEC
and/or Salmonella were excluded from the analysis. Total levels of immunoglob-
ulin (Ig) in serum were measured 1 or 2 days prior to infection by zinc sulfate
turbidity (ZST) assay. Only calves with a zinc sulfate turbidity measurement over
10 were used.
Two days before infection calves were transferred to high-security biocontain-
ment accommodation and housed in tanks on tenderfoot mats. The calves were
orally challenged with ca. 1010 CFU of STEC in 20 ml of antacid (1 g of MgO,
1 g of Mg trisilicate, and 1 g of NaHCO3 in H2O) just before their morning feed.
The bacterial strains STEC O5, STEC O5 efa1, STEC O111, and STEC O111
efa1::kanr were each administered to two 4-day-old and two 11-day-old calves (16
animals in total). During the next 7 days, the calves were observed twice daily for
signs of diarrhea, and fecal samples were taken. Viable STEC per gram of feces
were enumerated by plating triplicate 10-fold serial dilutions onto sorbitol Mac-
Conkey agar medium containing nalidixic acid (20 g/ml) and tellurite (2.5
g/ml). The fecal shedding data were statistically analyzed after a 10log trans-
formation for the effect of serotype, mutation, age of calf, and their interactions
by means of an F test, with the data taken as repeated measurements (Proc
Mixed, Statistical Analysis System; SAS Institute, Cary, N.C.).
Tissue sampling and microscopy. To examine the effect of mutation of efa1 on
bacterial association with the bovine intestinal mucosa, single 11-day-old calves
were separately inoculated with STEC O111 or STEC O111 efa1::kanr as de-
scribed above. Three days after inoculation samples of mucosa from the distal
ileum, cecum, spiral colon, and rectum were excised ante mortem under terminal
anesthesia and placed either in ice-cold mucosal medium for enumeration of
adherent bacteria or fixed in 4% (wt/vol) paraformaldehyde in PBS. For confocal
microscopy, 50-m-thick unembedded sections were cut on a Leica vibrating
microtome and permeabilized with 0.5% (vol/vol) Triton-X-100 in PBS for 30
min, and nonspecific binding sites were blocked with 0.5% (wt/vol) bovine serum
albumin in PBS as described previously (42, 55). Bacteria were detected with
1:100 rabbit anti-O111 typing serum (Veterinary Laboratories Agency, Wey-
bridge, United Kingdom) and 1:100 anti-rabbit Ig-Alexa568 (Molecular Probes,
Leiden, The Netherlands). Filamentous actin was stained with 1:10 Oregon
green 514-phalloidin (Molecular Probes). Stained sections were washed exten-
sively with PBS, mounted with Vectashield (Vector Laboratories, Burlingame,
Calif.), and analyzed at magnifications of 630 to 1,000 using a Leica TCS NT
confocal laser scanning microscope with version 1.6.587 software. At least three
1-cm-long sections were examined.
For electron microscopy, paraformaldehyde-fixed colonic mucosa was trans-
ferred to 2% (vol/vol) glutaraldehyde in 50 mM phosphate buffer overnight at
4°C. The mucosa was then postfixed for 8 h at room temperature with 1%
(wt/vol) osmium tetroxide in 50 mM phosphate buffer with the osmotic pressure
adjusted to 350 mosmol by the addition of sucrose. Specimens were dehydrated
in a graded series of ethanol solutions and embedded in Agar 100 resin (Agar
Scientific Ltd., Stansted, United Kingdom). Sections (ca. 1 m thick) were cut on
a Leica UCT microtome and contrasted with uranyl acetate and lead citrate
using a Leica EMStain machine (Leica Microsystems, Milton Keynes, United
Kingdom). Sections were imaged using an FEI Technai 12 transmission electron
microscope at 100 kV.
Detection of EspA and Tir by Western blotting. To measure expression and
secretion of LEE-encoded type III secreted proteins, bacteria were grown to
mid-logarithmic phase (A600, ca. 0.6) in Dulbecco’s modified Eagle medium.
Cells from 1 ml of each culture were collected by centrifugation and resuspended
in 50 l of sample buffer. Secreted proteins were precipitated from 45 ml of
filtered (pore size, 0.22 m) culture supernatants with 10% (vol/vol) trichloro-
acetic acid on ice for 1 h, resuspended in 1% sodium dodecyl sulfate (SDS), and
reprecipitated with acetone. Pellets were resuspended in 50 l sample buffer.
Proteins (ca. 25 g) were resolved by SDS–10 polyacrylamide gel electrophoresis
(SDS–10% PAGE) or –15% PAGE and transferred to nitrocellulose membranes
using a Bio-Rad Semi-Dry Trans-Blot apparatus at 15 V for 1 h. Membranes
were blocked with 5% (wt/vol) skim milk in Tris-buffered saline containing 0.1%
(vol/vol) Tween 20. To detect EspA we used a combination of four anti-EspA
monoclonal antibodies raised against purified EPEC EspA (23) and anti-mouse
Ig-horseradish peroxidase conjugate (Amersham). Tir was detected using a rab-
bit polyclonal antiserum against EPEC Tir (22) and anti-rabbit Ig-horseradish
peroxidase using an Amersham ECL chemiluminescence detection kit.
RESULTS
Efa1 influences adhesion of STEC O5 to cultured HeLa
cells. Consistent with the observations of Nicholls et al. (44),
we observed a 19-fold reduction in adherence of STEC O5
efa1 compared to the wild-type strain in a standard HeLa cell
adhesion assay (Fig. 1). Filamentous actin was nucleated under
the few adherent efa1 mutant bacteria that could be detected
(Fig. 1D), indicating that LEE-mediated attachment and rear-
rangement of cytoskeletal actin can still occur. No significant
reduction in adherence of the EPEC lifA mutant was ob-
served (data not shown), as reported by Klapproth et al. (30).
Mutation of the STEC O5 efa1 and EPEC lifA genes did not
alter the in vitro growth rates of the mutants compared to the
parent strains (data not shown).
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Lymphostatin inhibits the mitogen-activated proliferation
of bovine lymphocytes. We attempted to determine if lymphos-
tatin is active against bovine peripheral blood lymphocytes and
if STEC Efa1 also confers lymphostatin activity. Bovine PB-
MCs were stimulated with concanavalin A in the presence of
lysates from EPEC, EPEC lifA, STEC O5, STEC O5 efa1 or
a laboratory strain of E. coli (HB101). Lysates from the EPEC
wild-type strain, but not HB101, inhibited mitogen-activated
proliferation (Fig. 2). Deletion of the EPEC lifA gene abro-
gated this inhibitory effect indicating that lymphostatin is active
against bovine PBMCs. Lysates of the STEC O5 strains also
inhibited the mitogen-activated proliferation of bovine PB-
MCs, however other cytotoxins such as Shiga toxin 1 and/or
enterohemolysin may contribute to this effect since deletion of
efa1 did not relieve the inhibitory effect.
Efa1 influences STEC colonization and pathogenesis in
calves. To investigate the role of Efa1 in colonization of the
bovine intestine by STEC, we inoculated two 11-day-old con-
ventional Friesian bull calves each with STEC O5, STEC O5
efa1, STEC O111 or STEC O111 efa1::kanr by the oral route.
To investigate the induction of diarrhea, we also inoculated
duplicate 4-day-old calves with the STEC O5 and O111 wild-
type and efa1 mutant strains. No significant effect of age on the
course of fecal excretion of STEC was detected (P  0.08);
therefore, we analyzed the data from all calves given the wild-
type and efa1 mutant strain for the effect of the mutation. In all
cases the STEC O5 and O111 efa1 mutant strains were shed in
the feces in significantly lower numbers than the corresponding
wild-type strains (P values  0.05 at 6 days postinoculation)
(Fig. 3).
Consistent with previous observations (6, 21), the STEC O5
strain induced dysentery in 4-day-old calves lasting 3 or 4 days
from 3 days postinoculation, but did not induce dysentery in
11-day-old animals. The STEC O5 efa1 mutant did not in-
duce dysentery in 4- or 11-day-old animals, and the calves
remained clinically normal throughout with no overt pathology
visible at postmortem examination.
The STEC O111 efa1 mutant exhibits reduced adherence to
bovine colonic mucosa. To determine if mutations affecting the
efa1 gene influence adhesion to bovine intestinal epithelia we
inoculated single 11 day calves with STEC O111 wild-type or
STEC O111 efa1::kanr. Three days postinoculation samples of
intestinal mucosa were removed into either fixative for micro-
scopic analysis or mucosal medium for enumeration of bacte-
FIG. 1. Interaction of STEC O5 wild-type and efa1 mutant strains with cultured HeLa cells. Hemacolor-stained cells were examined for
adherent bacteria at a magnification of 630. (A) STEC O5; (B) STEC O5 efa1. (A and B) While the efa1 mutant strain adhered to HeLa cells
in significantly lower numbers, no difference was observed in the ability of the wild-type and mutant strains to form microcolonies and to nucleate
filamentous actin under the sites of bacterial attachment. (C) STEC O5; (D) STEC O5 efa1. (C and D) Bacteria were detected with rabbit anti-O5
lipopolysaccharide typing serum and anti-rabbit Ig-Alexa568 (red). Filamentous actin was stained with Oregon green 514-phalloidin (green).
Magnification, 1,000.
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ria. We detected large numbers of adherent wild-type STEC
O111 on the epithelium of spiral colon in dense microcolonies
by confocal microscopy, yet virtually no adherent bacteria at
the same site in calves infected with the efa1::kanr mutant (Fig.
4A and B). Analysis of colonic mucosa from the STEC O111-
infected calf by transmission electron microscopy showed the
bacteria to have formed classical AE lesions (Fig. 4C). Con-
sistent with the microscopic observations, we recovered a mean
of 9.2 0.06 log10 CFU/g STEC O111 wild-type from triplicate
full-thickness biopsies of spiral colon but only  2 log10 CFU/g
by enrichment from the same site in the calf infected with the
efa1::kanr mutant. Significantly fewer efa1 mutant bacteria
were also recovered from ileal, cecal, and rectal mucosa com-
pared to the wild-type strain (data not shown). Thus, mutation
FIG. 2. LifA inhibits the mitogen-activated proliferation of bovine peripheral blood lymphocytes. Bovine PBMCs were stimulated with
concanavalin A (5 g/ml) in the presence of 50 g of protein from E. coli HB101, EPEC, EPEC lifA, STEC O5, or STEC O5 efa1, and
proliferation was measured by incorporation of tritiated thymidine as described in Materials and Methods. The results are the means of
quadruplicate measurements from two independent experiments  standard errors of the means (error bars).
FIG. 3. Efa1 influences the course of fecal excretion of STEC serotypes O5 H and O111:H in calves. Mean fecal shedding data from four
calves inoculated with STEC O5 and STEC O5 efa1 (A) and STEC O111 and STEC O111 efa1::kanr (B) are shown. No significant effect of age
on fecal excretion was detected; therefore, the data obtained from 4- and 11-day-old calves inoculated with the same strain was pooled. Bacterial
recoveries from the feces were measured twice each day. The mean daily fecal count  standard error of the mean(error bars) is shown. Symbols:
✦, tendency towards significance (P  0.1); , significant difference (P  0.05).
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of efa1 significantly reduces association of STEC with the bo-
vine intestinal epithelium.
Deletion of efa1 influences expression and secretion of LEE-
encoded type III secreted proteins in STEC. To determine if
efa1 mutations also influence bacterial adhesion and coloniza-
tion by an indirect mechanism we analyzed expression and
secretion of EspA and Tir by EPEC and the STEC O5 wild-
type and mutant strains by Western blotting using specific
antisera. Our analysis shows that expression and secretion of
EspA and Tir by EPEC is not significantly affected by deletion
of lifA (Fig. 5). In, the STEC O5 efa1 mutant however, we
observed a reduction in the production and secretion of EspA
and Tir. However, we and others have reported that efa1 mu-
tations do not affect the ability of STEC to form microcolonies
and to nucleate filamentous actin under the sites of bacterial
attachment to cultured cells (Table 1) (44). This indicates that
expression and secretion of LEE-encoded type III secreted
proteins required for AE-lesion formation cannot be severely
affected by mutation of efa1.
DISCUSSION
Colonization of the bovine intestinal tract is influenced by
the bacterial outer membrane protein intimin (9). The LEE-
encoded Tir, EspA, and EspB secreted proteins are also re-
quired for intestinal colonization by REPEC in a rabbit model
following oral inoculation (1, 38). Intimin mutants do still
colonize some compartments of the bovine intestinal tract,
indicating that other accessory colonization factors may be
required. Several accessory adhesins have been identified in
STEC that mediate attachment to cultured cells, including
EspA (14), Iha (56), Efa1 (44) and several other genes iden-
tified by transposon mutagenesis of E. coli O157:H7 (57).
FIG. 4. Association of STEC O111 wild-type and efa1 mutant strains with bovine colonic epithelium. Confocal microscopy of 50-m-thick
vibrating microtome sections of spiral colon from 11-day-old calves 3 days after inoculation with STEC O111 wild-type (A) and STEC O111
efa1::kanr (B). Bacteria were detected with rabbit anti-O111 lipopolysaccharide typing serum and anti-rabbit Ig-Alexa568 (red). Filamentous actin
was stained with Oregon green 514-phalloidin (green). Magnification, 550. (C) Transmission electron micrograph showing AE lesions induced
by STEC O111 on the same biopsy of colonic epithelium. Scale bar  1 m.
FIG. 5. Effect of lifA and efa1 mutations on expression and secretion of LEE-encoded type III secreted proteins in EPEC and STEC O5,
respectively. Whole-cell and secreted protein fractions of EPEC, EPEC lifA, STEC O5, and STEC O5 efa1 were resolved by SDS–10% PAGE
for detection of Tir and by SDS–15% PAGE for detection of EspA. Proteins (25 g) were transferred to nitrocellulose membrane and probed using
specific antisera. Equivalent loading of proteins was confirmed by Coomassie blue staining of gels (data not shown).
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However, the role of these factors in colonization of the bovine
intestine has so far not been tested.
Persistent colonization of the bovine intestine by STEC may
also require bacterial interference with mucosal immune re-
sponses. Subversion of host cell functions and the modulation
of mucosal immunity by enteric pathogens are emerging
themes (12). Indeed it has been shown that EPEC uses the
LEE-encoded type III protein secretion system to inhibit
phagocytosis (18) and can also modulate apoptotic pathways
(25), presumably to their own benefit.
We report here the effect of mutations in the efa1 gene of
STEC serotypes O5 and O111 on intestinal colonization in 4-
and 11-day-old calves. Deletion of the efa1 gene in an STEC
O5 strain isolated from a case of calf dysentery dramatically
reduced adherence of the bacteria to cultured cells, consistent
with previous observations (44). Further, we found that lifA
expressed by EPEC is active against bovine peripheral blood
lymphocytes, as well as human and murine PBMCs (30, 32),
indicating that the almost identical efa1 gene may modulate
mucosal immune responses in the bovine host. We were unable
to determine if Efa1 expressed by STEC confers lymphostatin
activity against bovine PBMCs, probably owing to the secretion
of other potent cytotoxins by our strains. Indeed it has been
reported that Stx1 is a potent inhibitor of the proliferation of
bovine lymphocytes (41). Until STEC Efa1 has been shown to
act as a lymphotoxin in the same way as EPEC LifA we suggest
that the efa1 nomenclature is more appropriate for the STEC
gene despite the high levels of nucleotide and amino acid
identity.
Deletion of the efa1 gene in STEC O5 strain significantly
reduced fecal shedding of the organism following oral inocu-
lation of 4- and 11-day-old conventional calves. Furthermore,
the efa1 mutant strain induced no clinical signs in 4-day-old
calves, whereas the wild-type strain caused bloody diarrhea
lasting 3 to 4 days from 3 days postinoculation as reported
previously (6, 21). Thus, Efa1 would appear to influence intes-
tinal colonization and enteropathogenesis by STEC in calves.
We were unable to clone the efa1 gene for the purpose of
trans-complementation of the STEC O5 efa1 mutant. Cosmids
containing efa1/lifA are underrepresented in cosmid libraries
and are frequently unstable (32, 44), suggesting that overex-
pression of the gene may be toxic. A cosmid containing EPEC
lifA is available (pIV-8-A) (32); however, we were unable to
introduce this cosmid into the STEC O5 efa1 mutant by elec-
troporation, possibly owing to incompatibility with one of the
six endogenous plasmids (21). Rather, we tested an indepen-
dent efa1 mutant in a different STEC serotype for its ability to
colonize the bovine intestinal tract. The STEC O111 efa1::Kanr
mutant (44) was also shed in significantly lower numbers than
the corresponding wild-type strain. Thus, the possibility that
mutations outside efa1 are responsible for the observed reduc-
tion in intestinal colonization is minimal. We were unable to
introduce pIV-8-A into the STEC O111 efa1::kanr mutant
since this strain is naturally resistant to the cosmid-encoded
antibiotic resistance.
Consistent with the reduced fecal shedding of the STEC efa1
mutants, we recovered significantly fewer efa1 mutant bacteria
from colonic mucosa 3 days after oral inoculation of calves
compared to the wild type. Further, we observed very few
adherent bacteria on the colonic epithelium of calves infected
with the STEC O111 efa1 mutant by confocal microscopy. In
contrast, the wild-type strain formed extensive microcolonies
and AE lesions in the colon at 3 days postinoculation. Thus,
Efa1 influences association of non-O157 STEC with bovine
intestinal mucosa.
While E. coli O157:H7 lacks the full-length efa1 gene a
truncated version of efa1 exists in the chromosome (24, 47).
Recently, Tatsuno et al. (57) reported that a mini-Tn5Km2
transposon insertion upstream of the truncated efa1 gene re-
duces adherence of E. coli O157:H7 to Caco-2 cells (57). Fur-
ther, E. coli O157:H7 strains encode a full-length homologue
of efa1 (toxB/l7095) on the pO157 virulence plasmid (4, 30, 36,
44). The pO157 plasmid confers upon laboratory strains of E.
coli the ability to inhibit IL-2 and IL-4 synthesis in mitogen-
activated human PBMCs, and it has been assumed that this
lymphostatin-like activity is determined by toxB (30). However,
pO157 encodes several other putative virulence factors includ-
ing enterohemolysin, an extracellular serine protease, catalase-
peroxidase and a type II secretion system that may mediate the
inhibitory effect.
The toxB gene, like efa1, has also been implicated in adher-
ence. E. coli O157:H7 strains containing derivatives of pO157
that lack toxB exhibit reduced adherence to cultured epithelial
cells (58). The authors reported that toxB indirectly influences
adherence by modulating the production and secretion of
LEE-encoded type III secreted proteins that are required for
the formation of AE lesions (58). Mindful of the possibility of
pleiotropic effects of efa1 mutations we analyzed the produc-
tion and secretion of EspA and Tir by our EPEC and STEC O5
wild-type and mutant strains by Western blotting using specific
antisera. We observed no reduction in production or secretion
of EspA or Tir in the EPEC lifA mutant strain. However, a
reduction in EspA and Tir production and secretion was ob-
served in the STEC O5 efa1 mutant. This reduction in EspA
and Tir secretion was insufficient to prevent the nucleation of
filamentous actin under the sites of STEC attachment to cul-
tured cells (this study, 44). Since actin condensation under
adherent bacteria is dependent upon the translocation of LEE-
encoded type III secreted effectors, our data would indicate
that expression and secretion of Tir and EspA cannot be se-
verely affected. Considerable natural variation in the level of
secretion of the LEE-encoded Tir and EspD proteins has been
observed among STEC O157:H7 strains isolated from cattle
(40); however, it is not known if this correlates with the ability
of the strains to efficiently colonize the bovine intestine.
It is unclear why mutation of EPEC lifA produced different
phenotypes to mutation of the STEC O5 efa1 gene. EPEC lifA
mutants do not show significantly reduced adherence to cul-
tured cells (this study and reference 30); however, EPEC ex-
presses type IV bundle forming pili which may mediate the
initial interactions with cultured cells and mask the effect of
other adhesins. The reasons why mutation of efa1 in STEC, but
not lifA in EPEC, reduced expression and secretion of the
LEE-encoded effectors EspA and Tir are obscure. Studies on
the transcription and translation of LEE genes in EPEC and
STEC efa1/lifA mutants are required to fully characterize this
effect.
Efa1 is only the second STEC protein to be implicated in
intestinal colonization in calves. Efa1 may influence coloniza-
tion of the bovine intestine in several ways. It may act as an
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adhesin per se, as suggested by Nicholls et al. (44), it may
promote STEC survival in the bovine gut by modulating mu-
cosal immunity, or it may act indirectly by influencing the
expression and secretion of LEE-encoded proteins or other
membrane associated proteins that influence colonization.
These activities are not necessarily mutually exclusive and are
the subject of ongoing studies in our laboratory.
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